NCT05727904 2026-04-03Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.Iovance Biotherapeutics, Inc.Phase 3 Recruiting670 enrolled